Question 1

What is Silo Pharma?

Accepted Answer

Silo Pharma is a Company.

Question 2

How often does Silo Pharma appear in global news?

Accepted Answer

Tracked across 5 news events drawn from 31 articles.

Question 3

When was Silo Pharma first tracked by Ergen?

Accepted Answer

First tracked on Jul 07, 2026.

Question 4

When was Silo Pharma last mentioned in news?

Accepted Answer

Last active on Aug 18, 2026.

Question 5

What is Silo Pharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: 18 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Silo Pharma in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 5 events.

Question 7

What is the most recent event involving Silo Pharma?

Accepted Answer

Silo Pharma $4M Private Placement (Jul 10, 2026, 6 articles).

Question 8

How did the "Silo Pharma $4M Private Placement" event impact Silo Pharma?

Accepted Answer

Silo Pharma is the issuer of the private placement, raising $4 million upfront with potential additional proceeds from warrants. The capital will support working capital and general corporate purposes, aiding its developmental-stage biopharmaceutical programs.

Question 9

How did the "Silo Pharma Granted European PTSD Patent" event impact Silo Pharma?

Accepted Answer

Silo Pharma is the patent holder and developer of SPC-15. The European patent grant strengthens its IP portfolio and supports its strategy to commercialize the preventative PTSD treatment, potentially increasing its market value.

Question 10

How did the "Silo Pharma Canadian Patent Allowance" event impact Silo Pharma?

Accepted Answer

Silo Pharma received the Canadian patent allowance for its lead asset SPC-15, strengthening its IP portfolio and supporting its development plans. This is a positive regulatory milestone for the company.

Question 11

How did the "QwikAgents joins NVIDIA Developer Program" event impact Silo Pharma?

Accepted Answer

Silo Pharma is the parent company; the partnership may enhance its subsidiary's capabilities and market position, but Silo remains a developmental-stage biopharma firm.

Question 12

How did the "QwikAgents joins AMD AI Developer Program" event impact Silo Pharma?

Accepted Answer

Silo Pharma's subsidiary QwikAgents joined AMD's AI Developer Program, signaling expansion beyond biopharma into AI. This could diversify revenue streams but carries execution risk.

Question 13

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.